Uthealth Houston
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1967-01-01
- Employees
- 11
- Market Cap
- -
Interferon-Alpha for Diabetes Mellitus Type 1
Phase 2
Completed
- Conditions
- Insulin-Dependent Diabetes Mellitus
- Interventions
- Other: PlaceboDrug: 5,000 hrINF-alphaDrug: 30,000 units hrINF-alpha
- First Posted Date
- 2001-09-19
- Last Posted Date
- 2013-11-19
- Target Recruit Count
- 57
- Registration Number
- NCT00024518
- Locations
- 🇺🇸
University of Texas, Houston, Houston, Texas, United States
🇺🇸Children's Hospital - St. Paul, St. Paul, Minnesota, United States
🇺🇸National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Cardiovascular Risk Profile Among Mexican-Americans
Completed
- Conditions
- Heart DiseasesCardiovascular DiseasesAtherosclerosis
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2019-04-18
- Target Recruit Count
- 2058
- Registration Number
- NCT00005187
Physical Activity and Cardiovascular Risk in Black Girls
Completed
- Conditions
- Cardiovascular DiseasesObesityHeart DiseasesHypertension
Family Blood Pressure Program - GENOA
Completed
- Conditions
- Heart DiseasesHypertensionCoronary ArteriosclerosisCardiovascular Diseases
Molecular Epidemiology of Essential Hypertension
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesCoronary DiseaseHypertension
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2021-10-01
- Target Recruit Count
- 573
- Registration Number
- NCT00005377
Sustaining Women's Smoking Cessation Postpartum
Completed
- Conditions
- Lung DiseasesCardiovascular DiseasesHeart Diseases
Intervention for Resistant Pregnant Smokers
Completed
- Conditions
- Cardiovascular DiseasesLung Diseases, ObstructiveChronic Obstructive Pulmonary Disease
Epidemiology of Genetic Factors in Lipid Metabolism
Completed
- Conditions
- AtherosclerosisCardiovascular DiseasesHeart Diseases
Scleroderma Lung Disease
Phase 3
Completed
- Conditions
- Pulmonary FibrosisSystemic SclerodermaScleroderma, SystemicLung Diseases
- Interventions
- Drug: Placebo
- First Posted Date
- 2000-02-10
- Last Posted Date
- 2015-03-27
- Target Recruit Count
- 158
- Registration Number
- NCT00004563
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
Phase 4
Completed
- Conditions
- AlcoholismSmoking
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2010-10-01
- Target Recruit Count
- 200
- Registration Number
- NCT00000447
- Locations
- 🇺🇸
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath